Jan 29
|
Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline
|
Jan 29
|
GSK announces EMA accepted for review the MAA for depemokimab
|
Jan 29
|
The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings
|
Jan 27
|
GSK and Oxford researchers to create cancer vaccine to stop disease developing
|
Jan 27
|
Trending tickers: Nvidia, Alphabet, Alibaba, Novo Nordisk and GSK
|